|
PTIX Protagenic Therapeutics Inc 1022899 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-963,616.00 |
| Balance Sheet |
|
Current Assets
|
$709,871.00 |
|
Assets
|
$2,796,006.00 |
|
Current Liabilities
|
$1,072,614.00 |
|
Liabilities
|
$1,072,614.00 |
|
Equity
|
$1,723,392.00 |
|
Shares Out
|
1810208.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-944,298.00 |
|
Investing Cash Flow
|
$629,883.00 |
| Market Analysis |
Market Cap
|
$1,086,124.80 |
|
Price
|
$0.60 |
|
BVPS
|
0.95 |
|
PB
|
0.63 |
|
EPS
|
-0.53 |
|
FCF
|
$-947,595.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:06 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:55 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PTIX documents filed with the SEC.
PTIX Filings
Clear
